NanoGroup S.A. (WSE:NNG)

Market Cap	86.51M
Revenue (ttm)	100.00
Net Income (ttm)	-5.69M
Shares Out	31.63M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,717
Average Volume	36,298
Open	2.700
Previous Close	2.840
Day's Range	2.690 - 2.870
52-Week Range	1.040 - 4.370
Beta	0.95
RSI	34.84
Earnings Date	May 26, 2025

About NanoGroup

NanoGroup S.A. operates as a biotechnology company in Poland. The company develops and licenses early-stage pre-clinical and IND solutions to international biotech and pharma companies. It also manages a portfolio of companies that manages projects for the need of modern medicine in the field of oncology and transplantology. The company was incorporated in 2016 and is based in Warsaw, Poland.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2016
• Country: Poland
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NNG

Financial Performance

In 2024, NanoGroup's revenue was 2,100, an increase of 4.01% compared to the previous year's 2,019. Losses were -5.17 million, -34.50% less than in 2023.